Phase III trial of GSK 961081 monotherapy in patients with chronic obstructive pulmonary disease.

Trial Profile

Phase III trial of GSK 961081 monotherapy in patients with chronic obstructive pulmonary disease.

Planning
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2013

At a glance

  • Drugs Batefenterol (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 25 Jul 2013 This trial will not be initiated in 2013, according to a Theravance media release.
    • 06 May 2013 This trial is expected to be initiated in 2013, according to a Theravance media release.
    • 06 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top